BridgeMD
Tests treatment safety and results for Uterine Myoma
Official title Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
ClinicalTrials.gov ID: NCT06658145
What this study is testing
- What it's testing
- The modified vNOTES hysterectomy was accomplished and validated for efficacy and safety using a multi-access vaginal confinement instrument with a fully visualised vaginal access platform.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 60, women only
You may be able to join if
- Female patients ≤ 60years old
- Patients requiring total hysterectomy (with or without bilateral adjuncts or salpingectomy) due to uterine fibroids
- BMI ranges from 18.5 to 27.9kg/m2;
- Informed consent signed by the subject himself or his legal representative.
You likely can't join if
- Pregnant and lactating women;
- asexual life history, vaginal malformations or adhesions, postmenopausal vaginal atrophy and stenosis;
- Preoperative examination for malignant possibility
- Uterine volume ≥20 weeks, history of pelvic inflammatory disease, severe endometriosis, degree III or IV uterine prolapse; Previous surgical history...
- Patients known to have severe hepatic or renal dysfunction;
- Patients with known blood disorders, coagulation disorders, active bleeding at any site, or bleeding propensity;
See the full eligibility criteria
- Female patients ≤ 60years old
- Patients requiring total hysterectomy (with or without bilateral adjuncts or salpingectomy) due to uterine fibroids
- BMI ranges from 18.5 to 27.9kg/m2;
- Informed consent signed by the subject himself or his legal representative.
- Pregnant and lactating women;
- asexual life history, vaginal malformations or adhesions, postmenopausal vaginal atrophy and stenosis;
- Preoperative examination for malignant possibility
- Uterine volume ≥20 weeks, history of pelvic inflammatory disease, severe endometriosis, degree III or IV uterine prolapse; Previous surgical history of intestinal obstruction, recurrent pelvic inflammatory disease...
- Patients known to have severe hepatic or renal dysfunction;
- Patients with known blood disorders, coagulation disorders, active bleeding at any site, or bleeding propensity;
- complicated with serious diseases of central nervous system, cardiovascular system, liver and kidney, digestive tract, respiratory system, endocrine and metabolism (thyroid disease, Cushing\'s syndrome...
- patients with acute infection;
- Known to have participated in any other clinical trial or taken hormone therapy within 3 months;
- who cannot sign the informed consent;
- For those with known or suspected poor compliance who could not complete the trial.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, up to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.